Effects of Treatment with the DYRK1A Inhibitor CX-4945 on Down Syndrome Phenotypes in Ts65Dn Mice

This study highlights the neurodevelopmental differences in this mouse model of DS and importance of evaluating potential sex differences and explores a possible treatment that targets a trisomic gene as means to improve for detrimental DS phenotypes.